These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3762240)

  • 1. Maximizing compliance with hemoccult screening for colon cancer in clinical practice.
    Thompson RS; Michnich ME; Gray J; Friedlander L; Gilson B
    Med Care; 1986 Oct; 24(10):904-14. PubMed ID: 3762240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial to improve colon cancer screening in rural family medicine: an Iowa Research Network (IRENE) study.
    Levy BT; Xu Y; Daly JM; Ely JW
    J Am Board Fam Med; 2013; 26(5):486-97. PubMed ID: 24004700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient compliance with screening for fecal occult blood in family practice.
    Hoogewerf PE; Hislop TG; Morrison BJ; Burns SD; Sizto R
    CMAJ; 1987 Aug; 137(3):195-8. PubMed ID: 3607662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient compliance with colorectal cancer screening in general practice.
    Mant D; Fuller A; Northover J; Astrop P; Chivers A; Crockett A; Clements S; Lawrence M
    Br J Gen Pract; 1992 Jan; 42(354):18-20. PubMed ID: 1586526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting colon cancer screening behavior from health beliefs.
    Macrae FA; Hill DJ; St John DJ; Ambikapathy A; Garner JF
    Prev Med; 1984 Jan; 13(1):115-26. PubMed ID: 6718327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of family physicians in increasing annual fecal occult blood test screening coverage: a prospective intervention study.
    Vinker S; Nakar S; Rosenberg E; Kitai E
    Isr Med Assoc J; 2002 Jun; 4(6):424-5. PubMed ID: 12073414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial.
    Green BB; Anderson ML; Cook AJ; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2017 Nov; 123(22):4472-4480. PubMed ID: 28753230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Videotape-based decision aid for colon cancer screening. A randomized, controlled trial.
    Pignone M; Harris R; Kinsinger L
    Ann Intern Med; 2000 Nov; 133(10):761-9. PubMed ID: 11085838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of reminders to increase compliance with tetanus booster vaccination.
    Rosser WW; Hutchison BG; McDowell I; Newell C
    CMAJ; 1992 Mar; 146(6):911-7. PubMed ID: 1544078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health belief and compliance with screening for fecal occult blood.
    Hoogewerf PE; Hislop TG; Morrison BJ; Burns SD; Sizto R
    Soc Sci Med; 1990; 30(6):721-6. PubMed ID: 2315741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a computer to teach patients about fecal occult blood screening. A randomized trial.
    Miller DP; Kimberly JR; Case LD; Wofford JL
    J Gen Intern Med; 2005 Nov; 20(11):984-8. PubMed ID: 16307621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing.
    Stokamer CL; Tenner CT; Chaudhuri J; Vazquez E; Bini EJ
    J Gen Intern Med; 2005 Mar; 20(3):278-82. PubMed ID: 15836533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload.
    Pye G; Christie M; Chamberlain JO; Moss SM; Hardcastle JD
    J Epidemiol Community Health; 1988 Mar; 42(1):66-71. PubMed ID: 3418289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physicians' reminders promote annual fecal occult blood testing compliance].
    Vinker S; Shumla V; Kitai E
    Harefuah; 2000 Jun; 138(12):1019-21, 1088, 1087. PubMed ID: 10979422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
    Prince M; Lester L; Chiniwala R; Berger B
    World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
    Adamsen S; Kronborg O
    Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomised controlled trial in population-based screening programmes.
    Zorzi M; Giorgi Rossi P; Cogo C; Falcini F; Giorgi D; Grazzini G; Mariotti L; Matarese V; Soppelsa F; Senore C; Ferro A;
    Prev Med; 2014 Aug; 65():70-6. PubMed ID: 24811759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing compliance with screening mammography recommendations: a clinical trial in a primary care office.
    Mohler PJ
    Fam Med; 1995 Feb; 27(2):117-21. PubMed ID: 7737444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.